Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06429436 · ClinicalTrials.gov registry record · Phase 4
Vending Machine Naloxone Distribution for Your Community (VENDY)
A Phase 4 study of Opioid Overdose and Harm Reduction, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 4,000
- Enrollment target
- 3
- Study locations
NCT06429436: Recruiting Phase 4 study of Opioid Overdose and Harm Reduction, sponsored by University of Colorado, Denver.
NCT06429436 is a Phase 4 study of Opioid Overdose and Harm Reduction that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 4,000 participants, roughly in line with the 3,742-participant average among 8 other Opioid Overdose trials with a reported enrollment target. The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06429436, a Phase 4 study of Opioid Overdose and Harm Reduction, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 4,000 participants
- Enrollment target
- 3
- Study locations
Study Summary
Vending machines are an innovative strategy shown to increase access to naloxone, a medication used to reverse opioid overdose. The aim of this proposal is to study the reach of a community-initiated, stakeholder engaged adaptation of naloxone distribution, VEnding machine Naloxone Distribution for Your community (VENDY) program.
Primary Outcome
Reach will be assessed using monthly counts of naloxone distribution in the 6 months before and after VENDY implementation. Naloxone counts will include distribution from all sources within the organization and captured through pharmacy fills from the electronic health record and distribution tracking logs. Naloxone machine distribution will be added to the total monthly count in the post implementation phase and obtained using the vending machine electronic software (reporting date and time of
Conditions Studied
Interventions
- BEHAVIORAL VENDY
Study Locations (3)
Colorado
- Denver Health - Denver
- Summit County Public Health Department - Frisco
- Southern Colorado Harm Reduction Association - Pueblo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2024-06-01 |
| Est. Completion | 2026-06-30 |
| Phase | Phase 4 |
What NCT06429436 shows while recruiting
NCT06429436 is an interventional study that assigns participants to a tested intervention. Its 4,000 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 3,742-participant average among 8 other Opioid Overdose trials with a reported enrollment target.
The record links to 3 conditions, with Opioid Overdose appearing as the primary indexed condition, and to 1 intervention - of which VENDY is the first listed.
NCT06429436 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT06429436 about?
NCT06429436 is a clinical study titled "Vending Machine Naloxone Distribution for Your Community (VENDY)". Vending machines are an innovative strategy shown to increase access to naloxone, a medication used to reverse opioid overdose. The aim of this proposal is to study the reach of a community-initiated, stakeholder engaged adaptation of naloxone distribution, VEnding machine Naloxone Distribution for ...
What is the current status of trial NCT06429436?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 4,000 participants. The study started on 2024-06-01. Estimated completion is 2026-06-30.
What conditions does trial NCT06429436 study?
This clinical trial studies the following conditions: Opioid Overdose, Harm Reduction, Naloxone.
What interventions are being tested in trial NCT06429436?
The interventions under investigation include: VENDY (BEHAVIORAL).
Who is sponsoring clinical trial NCT06429436?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06429436 being conducted?
This trial has 3 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Overdose
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06429436's enrollment target sits among peer trials
4,000 2nd of 8 the highest of 8 other Opioid Overdose trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Overdose trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Young Houston Emergency Opioid Engagement System
RECRUITING · Phase 4
-
Improving Availability of Intranasal Naloxone
RECRUITING · NA
-
Machine-Learning Prediction and Reducing Overdoses With EHR Nudges
RECRUITING · NA
-
A Bundled Intervention
RECRUITING · Phase 1
-
Quantitative Xylazine Measurement in ED
RECRUITING
-
Health Insurance Instability and Mortality Among Patients Receiving Bup Tx for OUD
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
- NCT00811148 · 4,000 participants
Florida Center for Brain Tumor Research
- NCT00897117 · 4,000 participants
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
- NCT00899301 · 4,000 participants
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI